Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Hldgs Inc (NY: DNA )

1.350 +0.110 (+8.87%)
Official Closing Price Updated: 7:00 PM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 17,114,116
Open 1.260
Bid (Size) 1.330 (26)
Ask (Size) 1.350 (1)
Prev. Close 1.240
Today's Range 1.240 - 1.380
52wk Range 1.190 - 4.910
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Evogene Offers An Excellent Risk/Reward Ratio
We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their... 
Via Talk Markets
7 Penny Stocks With Massive Growth Potential
If you laugh at red ink, these tempting ideas just might be for you. 
Via InvestorPlace

Performance

YTD
-14.56%
-14.56%
1 Month
-15.62%
-15.62%
3 Month
-18.18%
-18.18%
6 Month
-54.08%
-54.08%
1 Year
-54.55%
-54.55%

More News

Read More
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
Via Benzinga
Buy the Dip: 2 Exceptional Growth Stocks to Grab Before the Next Bull Market
Via The Motley Fool
Earnings Scheduled For March 1, 2023
Via Benzinga
Ginkgo Bioworks Holdings's Earnings: A Preview
Via Benzinga
Is It Too Early to Invest in Ginkgo Bioworks?
Via The Motley Fool
GINKGO BIOWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
Cronos Group Reports 2022 Fourth Quarter and Full-Year Results
From Cronos Group Inc.
Via Globe NewsWire
To The Moon: Intuitive Machines Blasts 10x in a Week...But Why?
Via MarketBeat
This Biotech Is Already Using AI, but Is the Growth Stock a Buy?
Via The Motley Fool
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Ginkgo Bioworks Holdings Inc. (DNA) Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
2 Bruised Growth Stocks to Buy While They're Cheap
Via The Motley Fool
The Next Big Disruptors? 3 Biotech Stocks Making Headlines.
Via InvestorPlace
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
Via The Motley Fool
Investigation Announced for Investors Who Lost Money with NYSE: DNA Shares over Possible Violations of Securities Laws by Ginkgo Bioworks Holdings, Inc.
Via SBWire
GINKGO BIOWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
3 Penny Stocks That Could Rise 500% in 2023
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
What You Missed On Wall Street On Friday
Via Talk Markets
Three Pharma Stocks to Sell Before They Die
Via InvestorPlace
Down 76% This Year, Is This Growth Stock Now a Screaming Buy?
Via The Motley Fool
Analyzing Ginkgo Bioworks Holdings's Short Interest
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.